SG&A Expenses

$2.20B

TTM · Period ending: Jun 30, 2026 · USD

EW SG&A Expenses

Latest reported$2.20Bperiod endingJun 30, 2026

EW TTM SG&A Expenses ($223.20M → $2.20B)

TTM SG&A Expenses

High-resolution chart · PNG

EW sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edwards Lifesciences SG&A Expenses — Trailing twelve months (TTM) (USD)
Period ending	SG&A Expenses (USD)
Jun 30, 2026	2,200,900,000
Mar 31, 2026	2,141,700,000
Dec 31, 2025	2,085,200,000
Sep 30, 2025	1,974,200,000
Jun 30, 2025	1,881,000,000
Mar 31, 2025	1,829,800,000
Dec 31, 2024	1,792,500,000
Sep 30, 2024	1,717,200,000
Jun 30, 2024	1,677,700,000
Mar 31, 2024	1,637,300,000
Dec 31, 2023	1,645,200,000
Sep 30, 2023	1,639,600,000
Jun 30, 2023	1,635,000,000
Mar 31, 2023	1,633,600,000
Dec 31, 2022	1,567,600,000
Sep 30, 2022	1,580,600,000
Jun 30, 2022	1,567,400,000
Mar 31, 2022	1,532,500,000
Dec 31, 2021	1,493,100,000
Sep 30, 2021	1,407,800,000
Jun 30, 2021	1,351,200,000
Mar 31, 2021	1,252,900,000
Dec 31, 2020	1,230,600,000
Sep 30, 2020	1,239,600,000
Jun 30, 2020	1,238,900,000
Mar 31, 2020	1,272,100,000
Dec 31, 2019	1,244,100,000
Sep 30, 2019	1,184,700,000
Jun 30, 2019	1,147,000,000
Mar 31, 2019	1,111,900,000
Dec 31, 2018	1,086,200,000
Sep 30, 2018	1,063,299,999
Jun 30, 2018	1,038,399,999
Mar 31, 2018	1,008,199,999
Dec 31, 2017	982,399,999
Sep 30, 2017	950,600,000
Jun 30, 2017	935,900,000
Mar 31, 2017	921,000,000
Dec 31, 2016	904,600,000
Sep 30, 2016	893,300,000
Jun 30, 2016	875,800,000
Mar 31, 2016	860,900,000
Dec 31, 2015	850,700,000
Sep 30, 2015	851,500,000
Jun 30, 2015	861,700,000
Mar 31, 2015	863,300,000
Dec 31, 2014	858,000,000
Sep 30, 2014	825,400,000
Jun 30, 2014	783,700,000
Mar 31, 2014	757,600,000
Dec 31, 2013	745,600,000
Sep 30, 2013	733,000,000
Jun 30, 2013	720,300,000
Mar 31, 2013	713,300,000
Dec 31, 2012	705,300,000
Sep 30, 2012	690,800,000
Jun 30, 2012	688,500,000
Mar 31, 2012	669,300,000
Dec 31, 2011	642,400,000
Sep 30, 2011	621,400,000
Jun 30, 2011	588,900,000
Mar 31, 2011	566,300,000
Dec 31, 2010	550,000,000
Sep 30, 2010	539,900,000
Jun 30, 2010	533,000,000
Mar 31, 2010	520,900,000
Dec 31, 2009	508,800,000
Sep 30, 2009	496,700,000
Jun 30, 2009	489,900,000
Mar 31, 2009	487,900,000
Dec 31, 2008	480,600,000
Sep 30, 2008	474,900,000
Jun 30, 2008	458,800,000
Mar 31, 2008	434,000,000
Dec 31, 2007	418,000,000
Sep 30, 2007	398,600,000
Jun 30, 2007	387,100,000
Mar 31, 2007	382,400,000
Dec 31, 2006	375,800,000
Sep 30, 2006	367,800,000
Jun 30, 2006	362,000,000
Mar 31, 2006	355,100,000
Dec 31, 2005	348,700,000
Sep 30, 2005	344,300,000
Jun 30, 2005	338,100,000
Mar 31, 2005	329,000,000
Dec 31, 2004	319,900,000
Sep 30, 2004	309,400,000
Jun 30, 2004	300,200,000
Mar 31, 2004	295,000,000
Dec 31, 2003	289,900,000
Sep 30, 2003	286,400,000
Jun 30, 2003	270,100,000
Mar 31, 2003	248,600,000
Dec 31, 2002	227,900,000
Sep 30, 2002	209,300,000
Jun 30, 2002	201,500,000
Mar 31, 2002	199,900,000
Dec 31, 2001	203,000,000
Sep 30, 2001	210,500,000